EXIT Question Title 1. Who are you? I'm a female DIAGNOSED with a bleeding disorder. I'm a female with a DIAGNOSED collagen/soft tissue disorder - I experience bleeding symptoms. I'm a female with a DIAGNOSED collagen/soft tissue disorder & bleeding disorder. I'm a female LABELLED a carrier of a bleeding disorder - I experience bleeding symptoms. I'm a female LABELLED a carrier of a bleeding disorder - I have never experienced abnormal bleeding symptoms. I'm a female LABELLED a symptomatic carrier of a bleeding disorder - I have a treatment plan for my bleeding symptoms. I'm a female LABELLED a symptomatic carrier of a bleeding disorder - I have no treatment for my bleeding symptoms. I'm a female with UNDIAGNOSED bleeding symptoms. OK Question Title 2. What symptoms do you experience? Nose or Sinus bleeds Eye bleeds Stomach or Intestinal bleeds Gum or Throat bleeds Urinary bleeds Airway or Lung bleeds Vascular bleeds Cranial or Brain bleeds Muscle bleeds Soft Tissue bleeds Joint bleeds Joint Hypermobility (flexible joints, able to move further than usual range) Joint Subluxations (partial dislocation) or Joint Dislocations Bruising or Hematomas Heavy or long periods Ovary or Internal bleeding Miscellaneous vaginal bleeding OK Question Title 3. What would you like to know more about or experience in your community? Calculating blood loss through your period. What is normal blood loss during your period. How blood loss impacts iron levels and body function. Iron in diet vs infusions, regaining equilibrium. Joint bleeds, muscle bleeds, soft tissue bleeds, internal bleeds, the lot. Meet clinicians who are pro treating female bleeders with clotting options. How hormones and the menstruation cycle affects diagnosis. Clotting treatment options (i.e. tranexamic acid, desmopressin and factor products) Meet female patients who receive adequate care or factor product. The impact of diet, natural medicine & synthetic therapy on your hormonal health. Adequate care during pregnancy and birth. Why symptomatic carriers do not exist. Current achievements, progress and future goal for females with bleeding disorders. Experiences & all about sanitary pads, tampons, menstrual cups and reusable pads/underwear. Collecting clinical data and studies involving females with bleeding disorders. The outcome of females who resorted to gynaecological options because they couldn't access/weren't offered treatment. OK Question Title 4. Do you feel your gender has affected your ability/ease to obtain diagnosis? Yes, I found difficulty obtaining my correct diagnosis as a female. No, I had no difficulty obtaining my correct diagnosis as a female. I'm unsure. (or) Not applicable I have not been assessed. OK Question Title 5. Do you feel your gender has affected your ability/ease to obtain adequate care for your symptoms? Yes, I had issues accessing adequate treatment to manage all my bleeding symptoms as a female. No, I had no issue accessing adequate treatment to manage all my bleeding symptoms as a female. I'm unsure. (or) Not applicable I have not been assessed. OK Question Title 6. In what country do you live? Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Central African Republic Chad Chile China Colombia Comoros Congo Costa Rica Côte D'Ivoire Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea Bissau Guyana Haiti Holy See Honduras Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka State of Palestine Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Vietnam Yemen Zambia Zimbabwe OK DONE